RECRUITING

Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes

Description

This is a parallel group, randomized, double-blind, placebo-controlled clinical study assessing the safety and effects of a novel nutritional product on self-reported cognitive function and health in adults that reside in the USA. Participants will take their assigned study product (active or placebo) for 8 weeks and answer validated electronic surveys assessing cognitive function delivered to them through a text message (SMS) link or through email.

Conditions

AgingCognitive DeclineBrain FogCognitive Function
Talk to us

Related Conditions:

AgingCognitive DeclineBrain FogCognitive Function

Study Overview

On this page

Study Details

Study overview

This is a parallel group, randomized, double-blind, placebo-controlled clinical study assessing the safety and effects of a novel nutritional product on self-reported cognitive function and health in adults that reside in the USA. Participants will take their assigned study product (active or placebo) for 8 weeks and answer validated electronic surveys assessing cognitive function delivered to them through a text message (SMS) link or through email.

Radicle Clarity™ 25_RAM: A Randomized, Double-Blind, Placebo-Controlled Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes

Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes

Condition
Aging
Intervention / Treatment

-

Contacts and Locations

Encinitas

Radicle Science, Inc Office, Encinitas, California, United States, 92024

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adults, at least 40 years of age at the time of electronic consent, inclusive of all ethnicities, races, and gender identities
  • * Resides in the United States
  • * Has the opportunity for at least 30% improvement in their primary health outcome
  • * Expresses a willingness to take a study product and not know the product identity (active or placebo) until the end of the study
  • * Report being pregnant, trying to become pregnant, or breastfeeding
  • * Unable to provide a valid US shipping address and mobile phone number
  • * Reports current enrollment in another clinical trial
  • * Reports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day)
  • * Unable to read and understand English
  • * Reports a current and/or recent (up to 3 months ago) major illness and/or surgery that poses a known, significant safety risk.
  • * Reports a diagnosis of cardiac dysfunction, liver or kidney disease that presents a known contraindication and/or a significant safety risk with any of the study product ingredients.
  • * Reports taking medications that have a well-established moderate or severe interaction, posing a substantial safety risk with any of the study product ingredients.
  • * Reports current use of the primary ingredient(s) and/or similar product(s) to the active study product(s) that may limit the effects of the study products
  • * Lack of reliable daily access to the internet

Ages Eligible for Study

40 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Amazentis SA,

Susan Hewlings, PhD, PRINCIPAL_INVESTIGATOR, Radicle Science Inc.

Study Record Dates

2026-03-31